Search Results
58 items found for "Ovarian cancer"
- RGS5 maintaining vascular homeostasis is altered by the tumor microenvironment
RGS5 expression in the triple-negative (TNBCs) and non-triple-negative breast cancers (Non-TNBCs) was The effect of breast cancer cell-conditioned media (BC-CM) on the pro-inflammatory phenotype of VSMCs In contrast, in the context of breast cancer tissues, the role of RGS5 was completely disrupted. RGS5 expression was increased in the triple-negative breast cancer (TNBC) tissues and in the tumor blood Dan-Dan Zhang , Xiao-Fu Huang , Yu Song , Wen-Di Zhang , Rui-Juan Guo , Han Li , Mei Han Tags Breast cancer
- Ep 52 with Dr. Benjamin Myers
University of Utah School of Medicine in Salt Lake City, UT, and an investigator with the Huntsman Cancer focuses on Smoothened and other class F GPCRs which play essential roles in embryonic development and in cancer Ben studied developmental and cancer signaling as a postdoctoral fellow with Philip Beachy at Stanford
- Session VIII | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Institute for Diabetes and Cancer, Helmholtz Centre Munich, Germany, 2. " About Anastasia Georgiadi "Head of Junior Group Endocrine Pharmacology, Institute of Diabetes and Cancer Professional Background Since 2021 Group Leader, Institute for Diabetes and Cancer, Helmholtz Diabetes Centre, Munich 2018 - 2021 Project Team Leader, Institute for Diabetes and Cancer, Helmholtz Diabetes Munich 2015 - 2018 Postdoctoral fellow, Department of Adipose Tissue Biology, Institute for Diabetes and Cancer
- Posters | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
PDF Program HERE < Back to Full Agenda Posters Interrogating The Role Of CELSR1 (ADGRC1) In Breast Cancer Caroline Formstone Abstract "Breast cancer is the most common form of cancer amongst women. Recent studies identify CELSR1, a key PCP gene, as a novel biomarker for early-stage breast cancer. The impact of CELSR1 on cancer progression, however, is unclear. Notably, our pilot data from luminal-type breast cancer cell lines representative of breast carcinomas
- GPR4 in the pH-dependent migration of melanoma cells in the tumor microenvironment
2022 Abstract Due to its high metastatic potential, malignant melanoma is one of the deadliest skin cancers In melanoma as well as in other cancers, acidification of the tumor microenvironment (= TME, inverse
- Expression pattern and clinical significance of beta 2-adrenergic receptor in oral squamous cell carcinoma: an emerging prognostic indicator and future therapeutic target
However, the role of β2-AR in oral cancer is not well identified. Kumar Mohanty, Rajender Singh, Vijay Kumar, Uma Shankar Singh, Rakesh Kumar Singh Tags GPCR; OSCC; Oral cancer
- From outside to inside and back again: the lysophosphatidic acid-CCN axis in signal transduction
protein-coupled receptors (GPCRs), enhancing proliferation, adhesion, and migration in many types of cancer Our group previously reported that LPA induces production of CCN1 protein in human prostate cancer cell
- Session II | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Avila Zozaya "My doctoral research was focused on investigating the cellular effects of missense lung cancer-mutations Sciences, University of Alabama at Birmingham (UAB), Birmingham, Alabama, USA 5 O'Neal Comprehensive Cancer Van Meir pursued postdoctoral work at the Ludwig Institute for Cancer Research in San Diego and joined Van Meir has developed novel therapeutic approaches for cancer using oncolytic adenoviruses and anti-angiogenic translate these novel agents to testing in clinical trials with the hope to develop novel medicines for cancer
- Comparative Analysis of the GNAI Family Genes in Glioblastoma through Transcriptomics and Single-Cell Technologies
Published date October 23, 2023 Abstract Glioblastoma multiforme (GBM) is one of the most aggressive cancers We used The Cancer Genome Atlas (TCGA) GBM genomic dataset to identify differentially expressed genes
- Dr. GPCR Community Presentation | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Avila Zozaya "My doctoral research was focused on investigating the cellular effects of missense lung cancer-mutations
- Ep 135 with Dr. Katarzyna Marcinkiewicz
Weill Cornell Graduate School of Medical Sciences in New York City, studying epigenetic changes in cancer
- Session III | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Sabbagh undertook post-doctoral fellowships at the Ontario Cancer Institute and the University of Toronto projects aimed on drug discovery of small molecules for the treatment of inflammatory disorders and cancer Department of Biochemistry and Molecular Medicine, Institute for Research in Immunology and Cancer (IRIC the development of innovative treatments for a range of diseases, including psychiatric disorders and cancer
- Ep 58 with Dr. Juan José Fung
Scientist at GPCR Therapeutics, Inc , a drug discovery company focused on targeting GPCR heteromers in cancer
- Exploration of prognostic and treatment markers in hepatocellular carcinoma via GPCR-related genes analysis
Patients' data on HCC were sourced from the Liver Hepatocellular Carcinoma-Japan (LIRI-JP) and The Cancer dysfunction and exclusion (TIDE) algorithm was utilized to evaluate immune infiltration levels and genetic variations immunotherapy and common antitumor drugs was predicted via the database Genomics of Drug Sensitivity in Cancer
- Session IX / Technology capsule: Light on aGPCR signaling and function | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
His research experience includes phylogenetics and cancer epigenetics.
- FAQ | Dr. GPCR Ecosystem
If you choose not to continue, you can cancel anytime before the trial ends without being charged. How do I cancel my membership? You can cancel your membership by following these steps: Go to My Account. Select the membership you want to cancel and click Cancel Subscription.
- Student Flash Presentations | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Role Of GPR97/ADGRG3 In Neutrophil Biology Tyler Bernadyn Next Generation MBD2 inhibitors for Brain Cancer Formation in Li-Fraumeni Syndrome Alex Torrelli-Diljohn Abstract "Li-Fraumeni syndrome (LFS) is a rare cancer El Merahbi Rabih, Herzig Stephan , Georgiadi A , Helmholtz Center Munich, Institute of Diabetes and Cancer Research Group to identify novel prognostic biomarkers and therapeutic options for Metastatic Breast Cancer Tyler Bernadyn on the web LinkedIn Next Generation MBD2 inhibitors for Brain Cancer Therapy Jesse Stillwell
- CCR6 as a Potential Target for Therapeutic Antibodies for the Treatment of Inflammatory Diseases
This pathway is implicated in mechanisms related to many diseases, such as cancer, psoriasis, multiple
- Ep 78 with Dr. Stuart Maudsley
At the MRC he developed novel prostate cancer therapeutics based upon his research into GPCR pluridimensional
- Registration (private) | Dr. GPCR Ecosystem
GPCR Premium Membership *Automatically renews, see confirmation email for details *Cancel anytime *Free
- Dynamic Phosphoproteomics of BRS3 Activation Reveals the Hippo Signaling Pathway for Cell Migration
The lung cancer cell line H1299-BRS3 was treated with MK-5046, an agonist of BRS3, for different durations
- S1P Signaling Genes as Prominent Drivers of BCR-ABL1-Independent Imatinib Resistance and Six Herbal Compounds as Potential Drugs for Chronic Myeloid Leukemia
genes are promising therapeutic targets and plausible new innovation avenues to combat IM resistance in cancer
- Ep 151 with Dr GPCR Board
control cell signaling by protease-activated receptors (PARs) and the impact on vascular inflammation and cancer research has focused on PAR1, which has important functions in hemostasis, thrombosis, inflammation, and cancer
- Exploiting frequent and specific expression of PRL3 in pediatric solid tumors for first-in-child use of PRL3-zumab humanized antibody
of regenerating liver 3 (PRL3) is a specific tumor antigen overexpressed in a broad range of adult cancer
- Evolutionary diversity of CXCL16-CXCR6: Convergent substitutions and recurrent gene loss in sauropsids
This axis is linked to diseases like HIV/SIV, cancer, and COVID-19. Previous studies of the CXCL16-CXCR6 axis found genetic variation among species but were limited to primates
- Identification of S1PR4 as an immune modulator for favorable prognosis in HNSCC through machine learning
Authors Chenshen Huang , Fengshuo Zhu , Hao Zhang , Ning Wang , Qi Huang Tags Cancer , Machine learning
- GPCR Retreat 2023 | Dr. GPCR Ecosystem
world-class and diverse GPCR scientists working in the arenas of structure and signaling, neuroscience, cancer
- Session IV | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
of Medicine, where he studies BAI1's role in the brain and the radiobiology of treatments for brain cancer